Variables | Unadjusted model | Model 1 | Model 2 | Model 3 |
---|---|---|---|---|
ECT sessions (n) | ||||
 4 < n | 1.00 (Ref) | 1.00 (Ref) | 1.00 (Ref) | 1.00 (Ref) |
 4 ≤ n < 8 |  |  |  |  |
 8 ≤ n < 12 | 0.08 (0.02–0.32)** | 0.09 (0.03–0.29)** | 0.08 (0.02–0.29)** | 0.05 (0.01–0.20)** |
 12 ≤ n < 16 | 0.13 (0.03–0.68)* | 0.16 (0.05–0.56)** | 0.17 (0.05–0.61)** | 0.08 (0.02–0.34)** |
 16 ≤ n |  |  |  |  |
Age |  |  | 0.85 (0.74–0.98)* | 0.80 (0.68–0.94)** |
Psychiatric comorbidities | Â | Â | Â | Â |
 None |  |  | 1.00 (Ref) | 1.00 (Ref) |
 OCD |  |  | 9.46 (1.50–59.65)* | 10.86 (1.65–71.42)* |
Antidepressants | Â | Â | Â | Â |
 Sertraline |  |  |  | 1.00 (Ref) |
 Escitalopram |  |  |  | 3.76 (1.21–11.72)* |
Antipsychotics | Â | Â | Â | Â |
 Quetiapine |  |  |  | 1.00 (Ref) |
 Olanzapine |  |  |  | 0.44 (0.24–0.79)** |
 Aripiprazole |  |  |  | 0.35 (0.18–0.67)** |